https://www.beckershospitalreview.com/supply-chain/amazon-merck-a...

https://www.beckershospitalreview.c...ch-data-driven-drug-development-platform.html

 Accenture and Merck are building an informatics research platform on Amazon's cloud computing service Amazon Web Services to support data-driven drug development.
 The cloud-based platform will provide pharmaceutical, biotechnology and scientific institutions with access to research data from various applications, available through a single set of interfaces with integrated workflow and reporting capabilities. Through the platform, these organizations will be able to aggregate and analyse this data to support the early stages of drug development.
 Merck, as one of the early collaborators, will be the first pharmaceutical company to use the platform.
 The informatics research platform is part of an ongoing collaboration between management consulting and professional services firm Accenture and AWS through the Accenture AWS Business Group.

MedAdvisor are certainly targeting the same initiatives as their international counterparts.

I think we'll be hearing more about these types of activities. The recent announcement mentioned big pharma pay a setup fee on top of a charge per eligible patient. There was also a note about the Government providing funding to support early stages of drug development.